Generate a tailored SOP for Dr. Philip Connell. Improve your application with a focused, well-structured draft.
Philip Connell, MD, is an expert in radiotherapy with a particular focus on sarcomas, thoracic cancers, and pediatric malignancies. He has been recognized by Newsweek as one of 'America's Top Doctors' and by Chicago Magazine as a 'Top Doctor' in the Chicagoland region. He serves as the Associate Department Chair of Academic Affairs in the Department of Radiation Oncology. In addition to his clinical leadership, Connell is an active cancer researcher and received his laboratory training in cancer biology through a fellowship at the National Cancer Institute. His research program aims to identify molecular markers of treatment resistance and develop new anti-cancer agents to overcome molecular hurdles. His latest projects involve novel, high-throughput assays designed to identify potential drugs that modify DNA repair systems, potentially leading to new chemical compounds that can improve existing oncology therapies or block the mutagenic effects of chemotherapy and radiotherapy. Connell has received numerous awards for his contributions, including the American Society of Clinical Oncology Merit Award and the American Brachytherapy Society Research Award, among others. He has authored numerous medical reports and textbook chapters and serves as a reviewer for various medical journals.
University of Chicago • Chicago, IL
Serves as a Professor in the Department of Radiation Oncology.
Department of Philosophy